are people going blind from glp 1 Researchers Find Small Increased Risk of Sudden Vision Loss Associated With GLP-1 Medications Vision loss risks in patients

June 2026 will mark five years since GLP-1 medications were approved for obesity and overweight

Trapnell, C

Guidelines from anesthesia and surgical societies recommend holding the weekly formulations of these drugs for at least a week before surgery, so careful planning is required if a patient is using these therapies

TOP 5: Farxiga (Dapagliflozin) 2023 Sales: $5.963 billion Company: AstraZeneca First FDA Approval: January 13, 2014 Indications: Type 2 diabetes, type 1 diabetes, heart failure Farxiga is a novel, once-daily oral sodium-glucose co-transporter 2 (SGLT2) inhibitor

Add approximately 20mL of bacteriostatic water to the bottle as your base

Some medications reduce B12 absorption